Financial Performance - The company's revenue for the year ended September 30, 2024, was HKD 9,987,000, a decrease of 19.5% compared to HKD 12,331,000 for the year ended September 30, 2023[2]. - The net loss before tax for the year was HKD 8,851,000, compared to a loss of HKD 1,941,000 in the previous year, representing a significant increase in losses[2]. - The company reported a total comprehensive loss attributable to equity shareholders of HKD 8,857,000 for the year, compared to HKD 1,941,000 in the previous year[2]. - The company reported a loss attributable to equity shareholders of approximately HKD 8.857 million for the year 2024, compared to a loss of HKD 1.941 million in 2023[44]. - The net loss for the fiscal year increased by approximately 368.4% to about HKD 8.9 million, up from HKD 1.9 million in the previous year[72][81]. Revenue Breakdown - The financial advisory fee income from financial advisory services was HKD 7,246,000, down 29.9% from HKD 10,308,000 in the previous year[18]. - The independent financial advisory fee income increased to HKD 2,581,000, up 42% from HKD 1,823,000 in the previous year[18]. - The company's revenue from corporate finance advisory services decreased by approximately 18.7% to about HKD 10.0 million compared to the same period last year[51]. - The company's revenue for the fiscal year ending September 30, 2024, decreased by approximately 18.7% to about HKD 10.0 million, compared to HKD 12.3 million in the same period last year[72]. Expenses and Liabilities - Employee benefit expenses rose to HKD 11,016,000, up 17.4% from HKD 9,384,000 in the prior year[2]. - Trade receivables at the end of the year were HKD 7,809,000, an increase from HKD 6,246,000 in the previous year, with a significant increase in the provision for losses[27]. - The provision for trade receivables increased significantly to HKD 3,050,000 from HKD 322,000, indicating a deterioration in receivables quality[2]. - Current liabilities included lease liabilities of HKD 975 million in 2024, up from HKD 724 million in 2023, indicating an increase of about 34.7%[119]. Cash and Assets - As of September 30, 2024, the company's cash and cash equivalents were approximately HKD 17.7 million, down from HKD 24.0 million as of September 30, 2023[59]. - The company's total assets decreased to HKD 21,173 million in 2024 from HKD 39,579 million in 2023, a decline of approximately 46.5%[119]. - Cash and cash equivalents decreased to HKD 17,665 million in 2024 from HKD 23,967 million in 2023, a reduction of about 26.1%[119]. - The net current asset value was HKD 19,707 million in 2024 compared to HKD 30,518 million in 2023, a decrease of approximately 35.5%[119]. Corporate Governance and Compliance - The company has complied with all provisions of the corporate governance code throughout the year, with some deviations explained in the report[67]. - The company is focusing on maintaining high standards of corporate governance to meet the rising expectations of shareholders and investors[67]. - The company has adopted the GEM Listing Rules regarding the code for securities transactions by directors, ensuring compliance since the review year[89]. Future Plans and Strategies - The company plans to focus on securing larger transaction projects to generate higher fee income[53]. - The company is exploring non-financial business opportunities, specifically in the feed and probiotics sector in China[55]. - The company has not recorded any revenue from asset management advisory services during the fiscal year, but is actively engaging with potential clients for establishing financial asset investment funds[74]. Shareholder Information - The company did not declare any dividends for the year, consistent with the previous year[25]. - The board did not recommend a final dividend for the year ending September 30, 2024, consistent with no dividend in 2023[107]. - The company announced a conditional agreement to issue up to 104,700,000 new shares at HKD 0.057 per share, raising approximately HKD 5.97 million for general operating funds in the coming year[89]. Employment and Staffing - The group employed 17 staff members as of September 30, 2024, unchanged from 2023[115]. - The company granted a total of 100,000,000 share options to 18 eligible participants, including directors and senior management, under its share option scheme adopted on February 26, 2018[100].
宝积资本(08168) - 2024 - 年度业绩